GLP-1 drugs are now available across the Chandigarh Tricity — from aesthetic clinics, general physicians, online apps, and even pharmacies in some cases. Gini Advanced Care Hospital offers the Tricity's only endocrinologist-led, data-driven GLP-1 programme. Dr. Anil Bhansali (former Head of Endocrinology, PGIMER) has tracked outcomes in 1,200+ GLP-1 patients. The difference matters.
📍 Sector 69, Mohali · 0172 4120100 · Mon–Sat 10 AM–6 PM
GLP-1 drugs are now available across the Chandigarh Tricity — from aesthetic clinics, general physicians, online apps, and even pharmacies in some cases. This is genuinely dangerous. These are powerful drugs that affect insulin secretion, thyroid tissue, cardiac function, and gastric motility. Prescribing them without proper metabolic assessment, thyroid screening, and cardiac baseline is negligent.
At Gini, we have seen patients arrive having been on Mounjaro for 3 months with no baseline HbA1c, no thyroid screen, and no monitoring. We've had to take patients off medication for safety reasons. The drug is not the risk — the lack of supervision is.
Will you do a thyroid screen before prescribing — including history of thyroid C-cell tumours or MEN2?
Will you check my cardiac status — Echo or TMT — if I have heart disease risk factors?
What monitoring schedule will you maintain — and what will you check and how often?
How do you measure my metabolic response — not just weight, but HbA1c, kidney function, and lipid profile?
Are you an endocrinologist or a general practitioner? And what is your training in GLP-1 pharmacology?
Five things that distinguish a real GLP-1 programme from a weight loss service.
Each patient is assessed for their specific metabolic phenotype before drug selection. Insulin secretion pattern, insulin resistance profile, and glucose variability determine whether Mounjaro, Ozempic, Wegovy, or Rybelsus is the right choice.
Thyroid screening (TSH + C-cell history), cardiac assessment (Echo/TMT for at-risk patients), kidney function, liver function, and HbA1c — all done before the first prescription. No exceptions.
Drug choice is determined by clinical data and your metabolic profile — not by patient preference, marketing, or whatever is cheapest. Dr. Bhansali may recommend Rybelsus over Mounjaro if your phenotype indicates it.
HbA1c, lipid profile, kidney function, and metabolic markers are tracked every three months. The programme adjusts drug dose, titration schedule, and co-medications based on outcomes — not assumptions.
Dr. Bhansali's programme has tracked outcomes in 1,200+ GLP-1 patients. This cohort provides real-world data on drug response, side effect patterns, and long-term metabolic outcomes — knowledge no online app or GP prescriber can access.
Gini in Sector 69, Mohali serves patients from across the entire Chandigarh Tricity region and surrounding districts.
A summary of the four main GLP-1 options available at Gini. Full directory including domestic generics at /glp1-therapy-mohali →
GLP-1 drugs (Mounjaro, Ozempic, Wegovy, Rybelsus) are not on the CGHS formulary — the drug cost is not covered. However, CGHS covers the specialist consultation with Dr. Bhansali (reimbursable) and all monitoring tests at Gini's in-house NABH-accredited lab. For Tricity CGHS patients, the practical approach is to use CGHS for all monitoring and pay privately for the drug. Dr. Bhansali will recommend the most cost-effective option for your clinical situation.
Full CGHS GLP-1 guide →Serving all of Chandigarh, Mohali, Panchkula, Zirakpur, Kharar, and Derabassi. Endocrinologist-led. Data-tracked. Mon–Sat, 10 AM–6 PM.